RecruitingPhase 4NCT07178262

Erector Spinae Block in Reducing Peri-operative Opioid Consumption in Total Abdominal Hystrectomy

Opioid Sparing Effect of Erector Spinae Block in Patients Undergoing Total Abdominal Hysterectomy; A Randomized Control Trial


Sponsor

Kulsoom International Hospital

Enrollment

60 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Hystrectomy is a surgical procedure that involves removal of uterus from the body of patient using a lower abdominal incision. This is an extremely painful procedure which causes discomfort and greatly increases opioids consumption in the peri-operative period. This can be reduced by using nerve blocks such as Erector spinae plane block.


Eligibility

Sex: FEMALEMin Age: 16 YearsMax Age: 80 Years

Inclusion Criteria2

  • American Society of Anesthesiologists (ASA) class: I, II and III .
  • Elective Hysterectomy under General Anesthesia.

Exclusion Criteria5

  • Lack of consent
  • Body mass index \>35 kg/m2
  • Allergic to study medicine
  • Opioid abuse or misuse disorder
  • Chronic pain

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGErector Spinae (ESP) Block with Bupivacaine (Marcaine®)

Bilateral Erector Spinae Block at T10 level using 30ml of 0.25% Bupivacaine will be administered under Ultrasound guidance before surgical incision.

DRUGPlacebo

Bilateral Erector Spinae Block at T10 level using 30ml of Normal saline will be administered under Ultrasound guidance before surgical incision.


Locations(1)

Kulsoom Internation Hospital

Islamabad, Federal, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07178262


Related Trials